F. Gebel, F. Ramelli, U. Bürgi et al. The site of leakage of intrafollicular thyroglobulin into the blood stream in simple human goiter. J. Clin. Endocrinol. Metab. 57, 915–919 (1983). https://doi.org/10.1210/JCEM-57-5-915

Article  PubMed  Google Scholar 

M. Chambard, J. Mauchamp, O. Chabaud, Synthesis and apical and basolateral secretion of thyroglobulin by thyroid cell monolayers on permeable substrate: modulation by thyrotropin. J. Cell Physiol. 133, 37–45 (1987). https://doi.org/10.1002/JCP.1041330105

Article  PubMed  Google Scholar 

J.J.M. de Vijlder, C. Ris-Stalpers, T. Vulsma, On the origin of circulating thyroglobulin. Eur. J. Endocrinol. 140, 7–8 (1999). https://doi.org/10.1530/EJE.0.1400007

Article  PubMed  Google Scholar 

T. Aizawa, M. Ishihara, Y. Koizumi et al. Serum thyroglobulin concentration as an indicator for assessing thyroid stimulation in patients with Graves’ disease during antithyroid drug therapy. Am. J. Med. 89, 175–180 (1990). https://doi.org/10.1016/0002-9343(90)90296-P

Article  PubMed  Google Scholar 

L. Druetta, K. Croizet, H. Bornet, B. Rousset, Analyses of the molecular forms of serum thyroglobulin from patients with Graves’ disease, subacute thyroiditis or differentiated thyroid cancer by velocity sedimentation on sucrose gradient and Western blot. Eur. J. Endocrinol. 139, 498–507 (1998). https://doi.org/10.1530/EJE.0.1390498

Article  PubMed  Google Scholar 

S. Filetti, C. Durante, D. Hartl et al. Thyroid cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann. Oncol. 30, 1856–1883 (2019). https://doi.org/10.1093/ANNONC/MDZ400

Article  PubMed  Google Scholar 

B.R. Haugen, E.K. Alexander, K.C. Bible et al. 2015 American Thyroid Association Management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: the American Thyroid Association guidelines task force on thyroid nodules and differentiated thyroid cancer. Thyroid 26, 1 (2016). https://doi.org/10.1089/THY.2015.0020

Article  PubMed  PubMed Central  Google Scholar 

C.A. Lebbink, T.P. Links, A. Czarniecka et al. 2022 European Thyroid Association Guidelines for the management of pediatric thyroid nodules and differentiated thyroid carcinoma. Eur. Thyroid. J. 11 (2022). https://doi.org/10.1530/ETJ-22-0146

M. Stasiak, A. Lewiński, New aspects in the pathogenesis and management of subacute thyroiditis. Rev. Endocr. Metab. Disord. 22, 1027–1039 (2021). https://doi.org/10.1007/S11154-021-09648-Y/TABLES/2

Article  PubMed  PubMed Central  Google Scholar 

R. Domin, E. Szczepanek-Parulska, D. Dadej, M. Ruchała, Subacute thyroiditis—literature overview and COVID-19. J. Med Sci. 89, e472–e472 (2020). https://doi.org/10.20883/MEDICAL.E472

Article  Google Scholar 

M. Stasiak, B. Tymoniuk, R. Michalak et al. Subacute thyroiditis is associated with HLA-B*18:01, -DRB1*01 and -C*04:01—the significance of the new molecular background. J. Clin. Med. 9 (2020). https://doi.org/10.3390/JCM9020534

J. Slatosky, B. Shipton, H. Wahba, Thyroiditis: differential diagnosis and management. Am. Fam. Physician 61, 1047–1052 (2000)

PubMed  Google Scholar 

V.L. Teixeira, J.H. Romaldini, H.F. Rodrigues et al. Thyroid function during the spontaneous course of subacute thyroiditis. J. Nucl. Med. 26, 457–460 (1985)

PubMed  Google Scholar 

G. Madeddu, A.R. Casu, C. Costanza et al. Serum thyroglobulin levels in the diagnosis and follow-up of subacute “painful” thyroiditis: a sequential study. Arch. Intern Med. 145, 243–247 (1985). https://doi.org/10.1001/ARCHINTE.1985.00360020063012

Article  PubMed  Google Scholar 

M. YAMAMOTO, S. SAITO, T. SAKURADA et al. Effect of prednisolone and salicylate on serum thyroglobulin level in patients with subacute thyroiditis. Clin. Endocrinol. (Oxf.) 27, 339–344 (1987). https://doi.org/10.1111/J.1365-2265.1987.TB01160.X

Article  PubMed  Google Scholar 

P. Trimboli, C. Cappelli, L. Croce et al. COVID-19-associated subacute thyroiditis: evidence-based data from a systematic review. Front Endocrinol. (Lausanne) 12, 1 (2021). https://doi.org/10.3389/FENDO.2021.707726/FULL

Article  Google Scholar 

S. Ippolito, D. Gallo, A. Rossini et al. SARS-CoV-2 vaccine-associated subacute thyroiditis: insights from a systematic review. J. Endocrinol. Invest 45, 1189–1200 (2022). https://doi.org/10.1007/S40618-022-01747-0

Article  PubMed  PubMed Central  Google Scholar 

S.F. Assimakopoulos, G.K. Markantes, D. Papageorgiou et al. Low serum TSH in the acute phase of COVID-19 pneumonia: thyrotoxicosis or a face of “non-thyroidal illness syndrome”? Clin. Chem. Lab Med. 59, 420–423 (2021). https://doi.org/10.1515/CCLM-2021-0511/PDF

Article  Google Scholar 

J. Christensen, K. O’Callaghan, H. Sinclair et al. Risk factors, treatment and outcomes of subacute thyroiditis secondary to COVID-19: a systematic review. Intern Med. J. 52, 522–529 (2022). https://doi.org/10.1111/IMJ.15432

Article  PubMed  PubMed Central  Google Scholar 

S. Mondal, R. Dasgupta, M. Lodh, A. Ganguly, Subacute thyroiditis following recovery from COVID-19 infection: novel clinical findings from an Eastern Indian cohort. Postgrad. Med J. 0, 1–7 (2022). https://doi.org/10.1136/POSTGRADMEDJ-2021-141429

Article  Google Scholar 

P. Trimboli, C. Camponovo, S. Franscella et al. Subacute thyroiditis during the COVID-19 pandemic: searching for a clinical association with SARS-CoV-2. Int. J. Endocrinol. 2021, (2021). https://doi.org/10.1155/2021/5588592

I. Campi, I. Bulgarelli, A. Dubini et al. The spectrum of thyroid function tests during hospitalization for SARS COV-2 infection. Eur. J. Endocrinol. 184, 699–709 (2021). https://doi.org/10.1530/EJE-20-1391

Article  PubMed  PubMed Central  Google Scholar 

D.A. Vassiliadi, I. Ilias, M. Pratikaki et al. Thyroid hormone alterations in critically and non-critically ill patients with SARS-CoV-2 infection. Endocr. Connect 10, 646–655 (2021). https://doi.org/10.1530/EC-21-0029

Article  PubMed  PubMed Central  Google Scholar 

L. Giovanella, R.M. Ruggeri, P.P. Ovčariček et al. Prevalence of thyroid dysfunction in patients with COVID-19: a systematic review. Clin. Transl. Imaging 9, 233 (2021). https://doi.org/10.1007/S40336-021-00419-Y

Article  PubMed  PubMed Central  Google Scholar 

R. Świątkowska-Stodulska, A. Berlińska, E. Puchalska-Reglińska, Thyroid function, inflammatory response, and glucocorticoids in COVID-19. Front Endocrinol. (Lausanne) 0, 1534 (2022). https://doi.org/10.3389/FENDO.2022.939842

Article  Google Scholar 

A. Brancatella, D. Ricci, N. Viola et al. Subacute thyroiditis after sars-COV-2 Infection. J. Clin. Endocrinol. Metab. 105, 2367–2370 (2020). https://doi.org/10.1210/CLINEM/DGAA276

Article  Google Scholar 

R.M. Ruggeri, A. Campennì, M. Siracusa et al. Subacute thyroiditis in a patient infected with SARS-COV-2: an endocrine complication linked to the COVID-19 pandemic. Hormones 20, 219–221 (2021). https://doi.org/10.1007/S42000-020-00230-W/FIGURES/1

Article  PubMed  Google Scholar 

N. Viola, A. Brancatella, D. Sgrò et al. Clinical, biochemical features and functional outcome of patients with SARS-CoV-2-related subacute thyroiditis: a review. Endocrine 79, 448–454 (2023). https://doi.org/10.1007/S12020-022-03247-W/TABLES/1

Article  PubMed  Google Scholar 

A. Brancatella, N. Viola, G. Rutigliano et al. Subacute thyroiditis during the SARS-CoV-2 pandemic. J. Endocr. Soc. 5, 1–8 (2021). https://doi.org/10.1210/jendso/bvab130

Article  Google Scholar 

R. Świątkowska-Stodulska, A. Berlińska, E. Puchalska-Reglińska, Thyroglobulin levels in COVID-19-positive patients: correlations with thyroid function tests, inflammatory markers, and glucocorticoid use. Front Endocrinol. (Lausanne) 13, 3510 (2023). https://doi.org/10.3389/FENDO.2022.1031188

Article  Google Scholar 

R. Świątkowska-Stodulska, A. Berlińska, K. Stefańska et al. Endocrine autoimmunity in pregnancy. Front Immunol. 0, 2695 (2022). https://doi.org/10.3389/FIMMU.2022.907561

Article  Google Scholar 

A. Stagnaro-Green, Postpartum thyroiditis. J. Clin. Endocrinol. Metab. 87, 4042–4047 (2002). https://doi.org/10.1210/JC.2002-020524

Article  PubMed  Google Scholar 

Y. Hidaka, I. Nishi, H. Tamaki et al. Differentiation of postpartum thyrotoxicosis by serum thyroglobulin: usefulness of a new multisite immunoradiometric assay. Thyroid 4, 275–278 (1994). https://doi.org/10.1089/THY.1994.4.275

Article  PubMed  Google Scholar 

M.H. Samuels, Subacute, silent, and postpartum thyroiditis. Med. Clin. 96, 223–233 (2012). https://doi.org/10.1016/j.mcna.2012.01.003

Article  Google Scholar 

A.F. Muller, H.A. Drexhage, A. Berghout, Postpartum thyroiditis and autoimmune thyroiditis in women of childbearing age: recent insights and consequences for antenatal and postnatal care. Endocr. Rev. 22, 605–630 (2001). https://doi.org/10.1210/EDRV.22.5.0441

Article  PubMed  Google Scholar 

L. Wang, Y. Tang, Y. Yuan et al. Effects of thyroperoxidase antibody and thyroglobulin antibody on maternal and neonatal outcomes in pregnant women. Horm. Metab. Res. 54, 76–83 (2022). https://doi.org/10.1055/A-1731-7572

Article  PubMed  Google Scholar 

A.B. Parkes, E.G. Black, H. Adams et al. Serum thyroglobulin: an early indicator of autoimmune post-partum thyroiditis. Clin. Endocrinol. (Oxf.) 41, 9–14 (1994). https://doi.org/10.1111/J.1365-2265.1994.TB03777.X

Article  PubMed  Google Scholar 

D.B. Johnson, C.A. Nebhan, J.J. Moslehi, J.M. Balko, Immune-checkpoint inhibitors: long-term implications of toxicity. Nat. Rev. Clin. Oncol. 19, 254–267 (2022). https://doi.org/10.1038/s41571-022-00600-w

Article  PubMed  PubMed Central  Google Scholar 

C.A. Muir, A.M. Menzies, R. Clifton-Bligh, V.H.M. Tsang, Thyroid toxicity following immune checkpoint inhibitor treatment in advanced cancer. Thyroid 30, 1458–1469 (2020). https://doi.org/10.1089/THY.2020.0032

Article  PubMed  Google Scholar 

C.A. Muir, V.H.M. Tsang, A.M. Menzies, R.J. Clifton-Bligh, Immune related adverse events of the thyroid – a narrative review. Front. Endocrinol. (Lausanne) 13, (2022) https://doi.org/10.3389/FENDO.2022.886930

H.S. Baek, C. Jeong, K. Shin et al. Association between the type of thyroid dysfunction induced by immune checkpoint inhibitors and prognosis in cancer patients. BMC Endocr. Disord. 22, 1–9 (2022). https://doi.org/10.1186/S12902-022-01004-8/TABLES/5

Article